Inke S.A: APIs manufacturing plant.
01 1Inke SA
02 2Agno Pharma Jiangsu
03 1Apicore Pharmaceuticals Private Limited
04 1Enaltec Labs Private Limited
05 1Hetero Drugs Limited
06 1MSN Life Sciences Private Limited
07 1MYLAN LABORATORIES LIMITED
08 1Piramal Pharma Limited
09 1Rolabo Outsourcing S.L.
01 7TETRABENAZINE
02 2Tetrabenazine
03 1Tetrabenzine
01 4India
02 2Spain
03 4U.S.A
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0025
Start Marketing Date : 2021-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57821-010
Start Marketing Date : 2020-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57821-014
Start Marketing Date : 2023-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-179
Start Marketing Date : 2012-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0049
Start Marketing Date : 2017-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5.46kg/5.46kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0085
Start Marketing Date : 2008-08-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-076
Start Marketing Date : 2020-01-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65085-0064
Start Marketing Date : 2018-12-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63827-1013
Start Marketing Date : 2012-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-831
Start Marketing Date : 2015-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A CAS-58-46-8 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-58-46-8, including repackagers and relabelers. The FDA regulates CAS-58-46-8 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-58-46-8 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-58-46-8 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-58-46-8 supplier is an individual or a company that provides CAS-58-46-8 active pharmaceutical ingredient (API) or CAS-58-46-8 finished formulations upon request. The CAS-58-46-8 suppliers may include CAS-58-46-8 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-58-46-8 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-58-46-8 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-58-46-8 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-58-46-8 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-58-46-8 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-58-46-8 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-58-46-8 suppliers with NDC on PharmaCompass.
We have 9 companies offering CAS-58-46-8
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
